Skip to content
Journal article

Do statins cause myopathy by lowering vitamin E levels?

Galli F, Iuliano L...(+2 more)

Medical Hypotheses, vol. 74, issue 4 (2010) pp. 707-709

  • 9


    Mendeley users who have this article in their library.
  • 11


    Citations of this article.
  • 977


    ScienceDirect users who have downloaded this article.
Sign in to save reference


Statins and other lipid lowering drugs have been repeatedly described to decrease blood levels of minor fat soluble components such as vitamin E (as ??-tocopherol). Clinical consequences of this secondary state of deficiency have not been described so far, but recent biochemical and molecular evidence on homeostatic and molecular responses to vitamin E deficiency in skeletal muscle cells may suggest the hypothesis presented in this paper of a role as risk factor in the development of statin-associated myopathy. This hypothesis that needs to be further investigated, could suggest the need for precautionary measures during lipid lowering therapy, which include timely diagnosis and active prevention of vitamin E deficiency. ?? 2009 Elsevier Ltd. All rights reserved.

Find this document

Get full text

Cite this document

Choose a citation style from the tabs below